(Global Edition) From the BBC World Service … The White House is set to unveil sanctions against China today after finding it encourages theft or transfer of intellectual property. But China’s threatening to fight back … so is a trade war just over the horizon? Then, how’s this for irony: A French company is poised to win a contract to make Britain’s passports in a post-Brexit world. We’ll hear from the U.K. company that’s set to lose out on the production. Afterward, a trip to a business with a unique take on how to tackle the problem of throw-away plastics.
(Markets Edition) President Trump wants to use a multi-million media campaign to help combat the opioid epidemic. But do public health campaigns actually work? We'll look at some previous advertising efforts to steer people away from drugs. Afterwards, we'll discuss how Pittsburgh's plan to green up the city may leave low-income residents behind.
(U.S. Edition) Facebook has launched an internal investigation into what it sees as the misuse of its data by the U.K.-based firm Cambridge Analytica, which the Federal Trade Commission is also looking into. And this isn't the social media giant's first run in with the FTC. On today's show, we'll look at their complicated past. Afterwards, we'll explore how "opportunity zones" are trying to draw private investment by providing tax incentives, and then talk about the advantages of buying electric cars in Norway.
(Global Edition) From the BBC World Service … Aleksandr Kogan, the Cambridge Analytica academic who created the Facebook app that harvested data from millions of users, told the BBC this morning he’s been made out to be a scapegoat. You’ll hear from him why he believes the accuracy of his data has been “extremely exaggerated” and why he doesn’t think it could have swayed the 2016 presidential election.
(Markets Edition) Cambridge Analytica's decision to harvest the info of millions of Facebook users has jittered the markets, but investors may be worried about more than the story at hand. Max Wolffe, chief economist at the Phoenix Group, joined us to explain why. Afterwards, we'll look at what the interest rate forecast for the year looks like prior to the Fed's meeting today, and then discuss the latest updates with the Takata airbag recall.
(U.S. Edition) The U.K.-based data firm Cambridge Analytica continues to be embroiled in scandal. We'll look at how investors are reacting to reports that it used Facebook data to manipulate voters on behalf of the Trump campaign, and then talk about the release of a video showing Cambridge's CEO claiming his company was able to entrap foreign politicians. Plus: A look at why some states are pushing back against pharmaceutical coupons for branded drugs.